Insulin & Metabolism
GLP-1/GIP
Myth or Sci
Fat Facts
100

What hormone acts as a major brake on adipose lipolysis after eating?

Insulin.

100

What does GLP-1 generally do to appetite and satiety?

Decreases appetite and increases satiety.

100

“Carbohydrates are bad and should be avoided for weight loss.” Myth or science?

Myth. Carbohydrates are an important fuel; amount, quality, context and total dietary pattern matter.

100

Fat tissue is just passive storage for extra calories. True or false?

False. Adipose tissue is metabolically and hormonally active.

200

After a mixed high-carb/high-fat meal, which fuel's oxidation generally increases rapidly as carbohydrate availability rises?

Carbohydrate.

200

What additional receptor does tirzepatide activate that semaglutide does not?

GIP receptor.

200

Being in fat-burning mode automatically means you're losing body fat.” Myth or science?

Myth. Increased fat oxidation at a particular moment does not necessarily mean net body-fat loss over time.

200

Name two signaling substances released by adipose tissue.

Examples include leptin, adiponectin, IL-6 and other adipokines/cytokines.

300

What happens to adipose lipolysis as insulin falls between meals or during fasting?

Lipolysis generally increases, making stored fatty acids more available.

300

Name three major sites/systems affected by GLP-1–based therapy.

Brain/appetite centers, pancreas/glucose regulation and GI tract/gastric emptying.

300

“Separating all carbohydrates and fats guarantees greater fat loss.” Myth or science?

Myth. Fuel partitioning changes after meals, but sustained body-fat loss depends on longer-term energy balance and other factors.

300

As adipocytes enlarge and become dysfunctional, what process can contribute to insulin resistance?

Chronic low-grade inflammation/inflammatory signaling.

400

Sarah hasn't eaten since dinner. Her insulin is lower the next morning. Does that prove she's losing body fat?

No. Fat mobilization/oxidation may be higher, but net body-fat change depends on energy balance over time.

400

A patient says, “If GLP-1 reduces my hunger, I don't need to worry about nutrition or exercise.” How would you respond?

Medication is one tool. Adequate nutrition/protein, resistance training/movement, sleep/recovery and ongoing support remain important.

400

“Everyone who starts a GLP-1/GIP medication must stay on an injection for life.”

Myth as an absolute statement. Obesity is often chronic and weight regain after withdrawal is common, but long-term treatment decisions are individualized.

400

Why can losing weight make maintaining that loss biologically difficult?

Compensatory responses can include increased hunger, altered satiety signaling and reduced energy expenditure/adaptive thermogenesis.